Reply to Letter by Akboga et al Entitled "Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus?"

Balamir, Ilhan; Ates, Ihsan; Topcuoglu, Canan; Turhan, Turan

Balamir, Ilhan; Ates, Ihsan; Topcuoglu, Canan; Turhan, Turan.

Afiliação

Balamir I; Department of Biochemistry, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Ates I; Department of Internal Medicine, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Topcuoglu C; Department of Biochemistry, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Turhan T; Department of Biochemistry, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Angiology ; 71(5): 481, 2020 05.

Article em En | MEDLINE | ID: mdl-30092647

Assuntos

Diabetes Mellitus Tipo 2; Doenças Vasculares; Biomarcadores; Humanos; Proteoglicanas; Albumina Sérica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Angiology Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google